Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciplukan Topical Formulation in Psoriasis Vulgaris
NCT06887322Phase 2Enrolling by invitation
- Sponsor
- Universitas Padjadjaran
- Start
- Feb 2025
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of physalis angulata extract in Psoriasis vulgaris (PV), sponsored by Universitas Padjadjaran. Started Feb 2025; status: enrolling by invitation.
02
Drugs
physalis angulata extract
03
Conditions
Psoriasis vulgaris (PV)
Beyond the preview
Go deeper on NCT06887322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06887322.